Showing results (161-170 of 171) with videos related to
Sort By:
Pageof 18
Fitoterapia|February 12, 2025
Six new compounds with neuroprotective activity from the leaves of Paeonia lactiflora PallXin-Yu Min, Jia-Tong Wu, Meng-Ting Wang, et al.Science Bulletin|March 28, 2026
Germ layer specification and organotropism in lymphoma invasionYan Dong, Peng-Peng Xu, Xiao Han, et al.Journal of Pharmaceutical and Biomedical Analysis|February 22, 2025
An integrated analysis strategy for characterization of chromones and coumarins from Saposhnikovia divaricata (Turcz.) Schischk. by UHPLC-QTOF-MSZhi-Jiang Chen, Wei Guan, Yan-Ying Li, et al.Scientific Reports|October 8, 2017
Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine SiteDong-Jun Fu, Ling Fu, Ying-Chao Liu, et al.Biomedical Chromatography : BMC|May 13, 2025
A Comparative Research of the Flavonoid Metabolites From Viscum coloratum in Normal and RA Rats by an Integrated Analytical StrategyYu-Qing Wang, Wei Guan, Yan-Ying Li, et al.European Radiology|June 27, 2023
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching studyZhi-Cheng Jin, Bin-Yan Zhong, Jian-Jian Chen, et al.Cell Reports. Medicine|March 20, 2025
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathologyYu-Qing Wang, Shuo Wang, Hong-Mei Yi, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
A Novel Self-Regulated, Non-Directional Magnetic Thermos-Brachytherapy <sup>125</sup>I Seed Enhances Anticancer Efficacy by Rescuing Immune EscapeBin Xu, Ye-Ming Wu, Yi-Fei Cheng, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 22, 2026
Renal IGFBP6 Interacts With THBS1 to Drive Renal Cellular Senescence and FibrosisJu-Tao Yu, Chang-Geng Xu, Xiao-Wei Hu, et al.Hepatology (Baltimore, Md.)|November 10, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)Zhi-Cheng Jin, Jingwei Wei, Yu-Dong Xiao, et al.Pageof 18